French AFU Cancer Committee Guidelines-update 2022-2024: management of kidney cancer
P Bigot, P Barthelemy, R Boissier, ZE Khene… - Progrès en Urologie, 2022 - Elsevier
Aim To update the recommendations for the management of kidney cancers. Methods A
systematic review of the literature was conducted from 2015 to 2022. The most relevant …
systematic review of the literature was conducted from 2015 to 2022. The most relevant …
[HTML][HTML] Treatment strategies for hereditary kidney cancer: current recommendations and updates
A subset of renal tumors (5-8%) are associated with syndromes such as von Hippel-Lindau
(VHL) syndrome, Birt-Hogg-Dubé syndrome (BHD), tuberous sclerosis complex (TSC) …
(VHL) syndrome, Birt-Hogg-Dubé syndrome (BHD), tuberous sclerosis complex (TSC) …
Circulating succinate-modifying metabolites accurately classify and reflect the status of fumarate hydratase-deficient renal cell carcinoma
L Zheng, ZR Zhu, T Sneh, W Zhang, ZY Wang… - The Journal of Clinical …, 2023 - jci.org
Germline or somatic loss-of-function mutations of fumarate hydratase (FH) predispose
patients to an aggressive form of renal cell carcinoma (RCC). Since other than tumor …
patients to an aggressive form of renal cell carcinoma (RCC). Since other than tumor …
A 25 year perspective on the evolution and advances in an understanding of the biology, evaluation and treatment of kidney cancer
The diagnosis, evaluation and management of patients with renal cell carcinoma has
transformed in the 21st century. Utilizing biological discoveries and technological advances …
transformed in the 21st century. Utilizing biological discoveries and technological advances …
Guidelines on germline testing for urologic tumor syndromes
PT Gomella, JR Mark, VN Giri, WK Kelly… - European Urology …, 2022 - Elsevier
In the expanding precision medicine landscape, along with improvements in and the
availability of testing, the use of genetics in the evaluation and treatment of patients has …
availability of testing, the use of genetics in the evaluation and treatment of patients has …
Role of ultra-high b-value DWI in the imaging of hereditary leiomyomatosis and renal cell carcinoma (HLRCC)
Purpose Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome is
associated with an aggressive form of renal cell carcinoma with high risk of metastasis, even …
associated with an aggressive form of renal cell carcinoma with high risk of metastasis, even …
[PDF][PDF] Family history and risk of renal cell carcinoma: a national multiregister case-control study
RG Jakobsson, S Nasic, O Bratt, ME Johansson… - Journal of …, 2023 - journals.lww.com
Purpose: Our purpose was to investigate the association between family history of renal cell
carcinoma (RCC) and RCC risk. Materials and Methods: RCC cases diagnosed in Sweden …
carcinoma (RCC) and RCC risk. Materials and Methods: RCC cases diagnosed in Sweden …
[HTML][HTML] Advances in Molecular Mechanisms of Kidney Disease: Integrating Renal Tumorigenesis of Hereditary Cancer Syndrome
R Cicchetti, M Basconi, G Litterio, M Mascitti… - International Journal of …, 2024 - mdpi.com
Renal cell carcinoma (RCC) comprises various histologically distinct subtypes, each
characterized by specific genetic alterations, necessitating individualized management and …
characterized by specific genetic alterations, necessitating individualized management and …
X-capsular incision for tumor enucleation (X-CITE)-technique: A method to maximize renal parenchymal preservation for completely endophytic renal tumors
AH Lebastchi, B Haynes, S Gurram, G Bratslavsky… - Urology, 2021 - Elsevier
Objective To describe the X-Capsular Incision for Tumor Enucleation (X-CITE) technique to
resect endophytic renal tumors while preserving the overlying renal parenchyma. Subjects …
resect endophytic renal tumors while preserving the overlying renal parenchyma. Subjects …
Renal neoplasms in young adults
P Gopee-Ramanan, S Chin, C Lim, KP Shanbhogue… - Radiographics, 2022 - pubs.rsna.org
Renal cell carcinoma (RCC) is usually diagnosed in older adults (the median age of
diagnosis is 64 years). Although less common in patients younger than 45 years, RCCs in …
diagnosis is 64 years). Although less common in patients younger than 45 years, RCCs in …